Cas:335033-38-0 5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide manufacturer & supplier

We serve Chemical Name:5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide CAS:335033-38-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide

Chemical Name:5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide
CAS.NO:335033-38-0
Synonyms:5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide
Molecular Formula:C6H7Br3N2
Molecular Weight:346.84500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.91000
Exact Mass:343.81600
LogP:3.86050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide Use and application,5-bromo-3-(bromomethyl)pyridin-2-amine hydrobromide technical grade,usp/ep/jp grade.


Related News: During Covid-19, the company has helped fill a void in meeting API demand for medicines used to treat patients with the virus. In April of last year, Wavelength expanded its production of API for three generic drugs— sedative midazolam, muscle relaxant cisatracurium, and paralytic rocuronium — to help keep up with hospital demand. 7-[2-(2-Isobutyrylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetyl]-3,9-dioxo-1,4,7,10-tetraaza-cyclododecane-1-carboxylic acid 9H-fluoren-9-ylmethyl ester manufacturers More than 50% of patients with SLE develop permanent organ damage, caused by the disease or existing treatments, which exacerbates symptoms and increases the risk of mortality. dichloro(2-methylthiomethylpyridine)platinum(II) suppliers Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. 9-Chloro-6,11-dihydro-5H-pyrrolo(2,1-b)(3)benzazepin-11-one vendor & factory.